Immunocore Holdings plc
IMCR
$33.00
$1.133.55%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -305.06% | 121.13% | -372.10% | 175.21% | 52.46% |
| Total Depreciation and Amortization | -8.67% | -26.76% | 12.66% | 4.33% | -1.88% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 303.51% | -87.17% | 353.90% | -196.87% | -35.76% |
| Change in Net Operating Assets | 451.33% | 7.74% | -145.79% | -33.83% | 234.45% |
| Cash from Operations | 5,868.74% | 103.12% | -166.03% | -9.99% | 611.71% |
| Capital Expenditure | -38.93% | 91.69% | -332.85% | -150.15% | 23.02% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -400.00% | -- | -- | 100.00% | -- |
| Cash from Investing | -413.48% | 374.07% | -327.54% | 99.76% | -81,372.33% |
| Total Debt Issued | -- | -- | -- | -- | -100.00% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 43.87% | 363.82% | 177.78% | -33.56% | -94.82% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 100.00% | 90.88% |
| Cash from Financing | 43.87% | 104.95% | -26,115.66% | 124.21% | -100.21% |
| Foreign Exchange rate Adjustments | 40.85% | 164.65% | -206.10% | 7,826.42% | 80.13% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -47.49% | 125.74% | -350.25% | 110.00% | -184.02% |